Literature DB >> 28266731

Left ventricular myocardial function assessed by three-dimensional speckle tracking echocardiography in Takotsubo cardiomyopathy.

Yukari Kobayashi1,2, Hiroyuki Okura3, Yuhei Kobayashi1,2, Shuichiro Fukuda1, Atsushi Hirohata1, Kiyoshi Yoshida1.   

Abstract

BACKGROUND: We aimed to investigate left ventricular (LV) functional recovery in Takotsubo cardiomyopathy (TC) using three-dimensional (3D) speckle tracking echocardiography.
METHODS: Twenty-one patients with TC who underwent routine and 3D echocardiography as well as electrocardiography were enrolled. 3D images were analyzed to measure 3D radial strain and area tracking (area change of each LV segment). Postsystolic shortening (PSS) or thickening (PST) was defined as a further shortening or thickening occurred after the end-systole. 3D echocardiography and ECG were repeated at 4 weeks and 6 months later.
RESULTS: Mean age was 70.9±11.1 years, and 18 (86%) patients were female. All patients presented classical type of TC with apical ballooning. LV ejection fraction (EF) improved from 49.9±7.2 to 64.9±6.0% (P<.001) at 4 weeks without segmental wall-motion abnormality. However, PSS or PST still existed in 43% of LV segments, and electrocardiographic abnormality was also observed in 51% at 4 weeks and disappeared at 6 months. Mean 3D radial strain decreased from baseline to 6 months at base (36.1±19.6 vs 28.0±12.6%, P=.04), whereas it increased at mid (16.2±7.2 vs 28.7±9.1%, P=.03) and the apex (8.0±4.4 vs 21.2±7.9%, P<.001). Mean area tracking increased from baseline to 6 months at mid and apex (-28.5±9.5 vs -44.5±9.6%, P<.001 for mid, and -24.2±13.0 vs -42.9±16.8%, P=.002 for the apex), while it did not change at base (-37.0±8.9 vs -41.9±9.6%, P=NS).
CONCLUSIONS: Patients with TC show abnormal wall motion during acute phase. Even after LV wall-motion recovery, subtle abnormalities of regional LV function appear to persist at 4 weeks followed by normalization at 6 months.
© 2017, Wiley Periodicals, Inc.

Entities:  

Keywords:  Takotsubo cardiomyopathy; left ventricular function; strain imaging; three-dimensional echocardiography

Mesh:

Year:  2017        PMID: 28266731     DOI: 10.1111/echo.13492

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

1.  Temporal changes within mechanical dyssynchrony and rotational mechanics in Takotsubo syndrome: A cardiovascular magnetic resonance imaging study.

Authors:  Sören J Backhaus; Thomas Stiermaier; Torben Lange; Amedeo Chiribiri; Pablo Lamata; Johannes Uhlig; Johannes T Kowallick; Uwe Raaz; Adriana Villa; Joachim Lotz; Gerd Hasenfuß; Holger Thiele; Ingo Eitel; Andreas Schuster
Journal:  Int J Cardiol       Date:  2018-04-22       Impact factor: 4.164

2.  Takotsubo syndrome in elderly woman: The diagnosis by transthoracic echocardiography.

Authors:  Inggita Hanung Sulistya; Anggoro Budi Hartopo; Lucia Kris Dinarti; Budi Yuli Setianto
Journal:  SAGE Open Med Case Rep       Date:  2019-09-23

3.  Time Course of Functional Recovery in Takotsubo (Stress) Cardiomyopathy: A Serial Speckle Tracking Echocardiography and Electrocardiography Study.

Authors:  Mirae Lee
Journal:  J Cardiovasc Imaging       Date:  2020-01

4.  Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE).

Authors:  Rodolfo Citro; Hiroyuki Okura; Jelena R Ghadri; Chisato Izumi; Patrick Meimoun; Masaki Izumo; Dana Dawson; Shuichiro Kaji; Ingo Eitel; Nobuyuki Kagiyama; Yukari Kobayashi; Christian Templin; Victoria Delgado; Satoshi Nakatani; Bogdan A Popescu
Journal:  J Echocardiogr       Date:  2020-09-04

Review 5.  Role of Multimodality Imaging in the Assessment of Myocardial Infarction With Nonobstructive Coronary Arteries: Beyond Conventional Coronary Angiography.

Authors:  Brent Gudenkauf; Allison G Hays; Jacqueline Tamis-Holland; Jeffrey Trost; Daniel I Ambinder; Katherine C Wu; Armin Arbab-Zadeh; Roger S Blumenthal; Garima Sharma
Journal:  J Am Heart Assoc       Date:  2021-12-31       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.